Actively Recruiting

Phase 4
Age: 18Years - 41Years
FEMALE
Healthy Volunteers
NCT06896617

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Led by Fundacion Clinic per a la Recerca Biomédica · Updated on 2025-04-02

334

Participants Needed

1

Research Sites

98 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.

CONDITIONS

Official Title

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Who Can Participate

Age: 18Years - 41Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients 18 to 37 years old at oocyte retrieval and under 41 years at embryo transfer
  • Regular menstrual cycles between 24 and 35 days
  • Availability of cryopreserved blastocysts from own gametes
  • Indication for single embryo transfer
  • Candidates for either programmed or natural frozen embryo transfer without contraindications
Not Eligible

You will not qualify if you...

  • Recurrent pregnancy loss (3 or more)
  • Recurrent implantation failure in previous IVF treatments (3 or more unsuccessful embryo transfers)
  • Diagnosis of polycystic ovarian syndrome, diabetes mellitus, chronic arterial hypertension, maternal heart disease, or autoimmune diseases like SLE or APS
  • Active treatment with aspirin, heparin, anticoagulants, antihypertensives, or other circulation/coagulation drugs
  • Indication for Preimplantation Genetic Testing (PGT)
  • Multiple pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Laura Burunat

Barcelona, Spain, Spain, 08036

Actively Recruiting

Loading map...

Research Team

L

Laura B Burunat, Graduate

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here